Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Amit Tiwari to Antineoplastic Agents

This is a "connection" page, showing publications Amit Tiwari has written about Antineoplastic Agents.

 
Connection Strength
 
 
 
4.883
 
  1. Neupane R, Karthikeyan C, Malla S, Khan JT, Ashby CR, Subbiah Hari Narayana Moorthy N, Trivedi P, Yadav H, Jayachandra Babu R, Hassan N, Boddu SHS, Tiwari AK. Identification and Mechanistic Profiling of Indolin-2-One Derivatives That Induce ROS-Driven Intrinsic Apoptosis in Prostate and Colorectal Cancer Cells. J Biochem Mol Toxicol. 2025 Nov; 39(11):e70545.
    View in: PubMed
    Score: 0.538
  2. Amawi H, Hammad AM, Hall FS, Hussein N, Rataan AO, Mrayyan A, Al-Kofahi T, Hmedat A, Ashby CR, Tiwari AK. Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer. Cancer Biol Med. 2025 Sep 29; 22(10):1158-80.
    View in: PubMed
    Score: 0.535
  3. Neupane R, Karthikeyan C, Piedra V, Pasternak M, Boddu SHS, Ashby CR, Babu RJ, Tiwari AK. Novel macropinocytosis inducers selectively modulate intracellular delivery of small and macromolecules in cancer cells. Int J Biol Macromol. 2025 Sep; 322(Pt 3):146366.
    View in: PubMed
    Score: 0.529
  4. Bachu RD, Abou-Dahech M, Balaji S, Boddu SHS, Amos S, Singh V, Babu RJ, Tiwari AK. Oncology biosimilars: New developments and future directions. Cancer Rep (Hoboken). 2022 11; 5(11):e1720.
    View in: PubMed
    Score: 0.435
  5. Hussein NA, Malla S, Pasternak MA, Terrero D, Brown NG, Ashby CR, Assaraf YG, Chen ZS, Tiwari AK. The role of endolysosomal trafficking in anticancer drug resistance. Drug Resist Updat. 2021 07; 57:100769.
    View in: PubMed
    Score: 0.397
  6. Amawi H, Aljabali AAA, Boddu SHS, Amawi S, Obeid MA, Ashby CR, Tiwari AK. The use of zebrafish model in prostate cancer therapeutic development and discovery. Cancer Chemother Pharmacol. 2021 03; 87(3):311-325.
    View in: PubMed
    Score: 0.385
  7. Al-Oudat BA, Ramapuram H, Malla S, Audat SA, Hussein N, Len JM, Kumari S, Bedi MF, Ashby CR, Tiwari AK. Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological Evaluation. Molecules. 2020 Jul 04; 25(13).
    View in: PubMed
    Score: 0.372
  8. Karthikeyan C, Amawi H, Viana AG, Sanglard L, Hussein N, Saddler M, Ashby CR, Moorthy NSHN, Trivedi P, Tiwari AK. lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest. Bioorg Med Chem Lett. 2018 07 15; 28(13):2244-2249.
    View in: PubMed
    Score: 0.321
  9. Amawi H, Karthikeyan C, Pathak R, Hussein N, Christman R, Robey R, Ashby CR, Trivedi P, Malhotra A, Tiwari AK. Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe. Eur J Med Chem. 2017 Sep 29; 138:1053-1065.
    View in: PubMed
    Score: 0.303
  10. Wang Q, Li F, Tiwari AK, Babu RJ. An up-To-Date Review of Elesclomol and Its Nano-Formulations in Cancer Therapy. Cancer Rep (Hoboken). 2025 Apr; 8(4):e70193.
    View in: PubMed
    Score: 0.129
  11. Singh V, Shirbhate E, Kore R, Vishwakarma S, Parveen S, Veerasamy R, Tiwari AK, Rajak H. Microbial Metabolites-induced Epigenetic Modifications for Inhibition of Colorectal Cancer: Current Status and Future Perspectives. Mini Rev Med Chem. 2025; 25(1):76-93.
    View in: PubMed
    Score: 0.127
  12. Shirbhate E, Singh V, Kore R, Vishwakarma S, Veerasamy R, Tiwari AK, Rajak H. The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance. Curr Top Med Chem. 2024; 24(6):523-540.
    View in: PubMed
    Score: 0.119
  13. Shirbhate E, Singh V, Mishra A, Jahoriya V, Veerasamy R, Tiwari AK, Rajak H. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer. Mini Rev Med Chem. 2024; 24(15):1449-1468.
    View in: PubMed
    Score: 0.119
  14. Shirbhate E, Singh V, Jahoriya V, Mishra A, Veerasamy R, Tiwari AK, Rajak H. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment. Eur J Med Chem. 2024 Jan 05; 263:115938.
    View in: PubMed
    Score: 0.117
  15. Thakur CK, Neupane R, Karthikeyan C, Ashby CR, Babu RJ, Boddu SHS, Tiwari AK, Moorthy NSHN. Lysinated Multiwalled Carbon Nanotubes with Carbohydrate Ligands as an Effective Nanocarrier for Targeted Doxorubicin Delivery to Breast Cancer Cells. Molecules. 2022 Nov 02; 27(21).
    View in: PubMed
    Score: 0.109
  16. Alrbyawi H, Poudel I, Annaji M, Arnold RD, Tiwari AK, Babu RJ. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery. Pharm Nanotechnol. 2022; 10(1):3-23.
    View in: PubMed
    Score: 0.103
  17. Neupane R, Malla S, Abou-Dahech MS, Balaji S, Kumari S, Waiker DK, Moorthy NSHN, Trivedi P, Ashby CR, Karthikeyan C, Tiwari AK. Antiproliferative Efficacy of N-(3-chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine, DW-8, in Colon Cancer Cells Is Mediated by Intrinsic Apoptosis. Molecules. 2021 Jul 22; 26(15).
    View in: PubMed
    Score: 0.100
  18. Esmati N, Maddirala AR, Hussein N, Amawi H, Tiwari AK, Andreana PR. Efficient syntheses and anti-cancer activity of xenortides A-D including ent/epi-stereoisomers. Org Biomol Chem. 2018 07 25; 16(29):5332-5342.
    View in: PubMed
    Score: 0.081
  19. Shirbhate E, Singh V, Kore R, Koch B, Veerasamy R, Tiwari AK, Rajak H. Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy. Expert Rev Anticancer Ther. 2025 Feb; 25(2):121-141.
    View in: PubMed
    Score: 0.032
  20. Stouffer M, Wandling E, Dickson L, Lin S, Duan H, Powe E, Jean-Louis D, Tiwari AK, Amos S. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines. Cancer Rep (Hoboken). 2024 May; 7(5):e2051.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.